Pasithea Therapeutics Corp (KTTA) Q1 2026 Earnings Call Transcript
Definium Therapeutics (DFTX) reported that its lead psychedelic candidate DT120 ODT has fully enrolled the EMERGE Phase III trial in major depressive disorder, with top‑line data expected in late Q2 2026. The VOYAGE Phase III study for generalized anxiety disorder is about 80% enrolled and aims to release results in early Q3, while a blinded sample‑size re‑estimation confirmed no need for additional participants, suggesting statistical power above 99%. The company also activated the first sites for the ASCEND MDD study and noted rapid progress on the PANORAMA GAD trial. Cash and investments total $411.6 million, extending the runway to 2028.
CervoMed Inc (CRVO) Q1 2026 Earnings Call Transcript
CONMED Corp reported Q1 2026 revenue of $317 million, a 1.3% decline, driven by the exit of its gastrointestinal product line. Excluding the GI exit, organic sales rose 2.1% and orthopedics grew 4.5% in constant currency, while general surgery remained flat....
Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously
Shyld AI announced a $13.4 million seed round led by Aulis Capital to scale its AI‑enabled UV disinfection devices for hospital rooms. The system autonomously detects occupancy, triggers targeted UV exposure, and logs cleaning activity, cutting pathogen levels by 93 % in...
New Radiopharmaceutical Achieves Remission in Difficult-to-Treat Pancreatic Cancer
Researchers have unveiled a novel radiopharmaceutical, ¹⁷⁷Lu‑AKIR001, that homes in on the CD44v6 protein variant prevalent in pancreatic ductal adenocarcinoma (PDAC). In mouse xenograft studies, a single 12 MBq dose achieved complete remission in 40% of subjects when used alone and...
Dexcom Unveils Next-Generation G8 CGM for Real-Time Glucose Monitoring
Dexcom announced its next‑generation G8 continuous glucose monitor at Investor Day, branding it as a completely new product platform built on a novel silicon chip and adaptive algorithm. The G8 offers a 50% smaller form factor than the G7 and...
Sick and Wrong: Ontario Auditors Find Doctors' AI Note Takers Routinely Blow Basic Facts
Ontario’s Auditor General audited 20 AI‑scribe vendors and found pervasive errors. Nine systems fabricated treatment suggestions, twelve inserted wrong drug data, and seventeen missed key mental‑health details. The evaluation framework gave minimal weight to accuracy, with only 4% of the...
REDOX-AHF: Less Oxygen May Be More for Hospitalized Acute HF Patients
The REDOX‑AHF trial randomized 135 hospitalized acute heart‑failure patients to either a restrictive oxygen strategy (target SpO₂ 90%) or a liberal strategy (target SpO₂ 96%). The restrictive arm achieved a greater 24‑hour drop in lung‑fluid content (2.4 % absolute difference, p = 0.01) and showed...
CMS Moratorium: What A Nationwide Freeze Means For Home Health Growth
CMS announced a six‑month nationwide moratorium on new Medicare‑certified home health and hospice agency enrollments, extending a tool first used in 2013. The freeze blocks de novo growth, forcing providers to rely on existing locations for revenue expansion. While current...
CMS Releases Details to Download Upcoming CAH Payment Patterns Report
The Centers for Medicare & Medicaid Services (CMS) announced details for downloading its fiscal year 2025 Program for Evaluating Payment Patterns Electronic Report (PEPPER) focused on critical access hospitals. The report, slated for release later this month, aggregates provider‑specific Medicare...
UPDATE - Ongoing Salmonella Outbreaks Linked to Backyard Poultry Sickens 150 More People with over a Quarter of Cases in...
The CDC has added 150 new Salmonella infections to three multistate outbreaks tied to backyard poultry, raising the total to 184 cases across 18 states. The surge includes 53 hospitalizations and one death, with more than a quarter of patients...
Ardent Health, Fujifilm Team Up to Deliver Enterprise Imaging Solutions
Ardent Health has partnered with Fujifilm Healthcare Americas to roll out the Synapse enterprise imaging platform across its acute‑care hospitals in six states. The solution unifies radiology, cardiology and mammography images into a single PACS viewer and integrates directly with...
Integrating Sarcopenia Into ICU-Acquired Weakness Risk Stratification: A Machine Learning–Based Prediction Model for Critical Care
A retrospective study of 1,324 ICU patients found that sarcopenia significantly predicts ICU‑acquired weakness (ICU‑AW). Using six variables—age, APACHE II score, sarcopenia, sepsis, mechanical ventilation, and lactate—the researchers trained ten machine‑learning models and identified XGBoost as the top performer (AUC ≈ 0.84). SHAP...
AHA Healthier Together Conference Concludes with Sessions on AI, Person-Centered Care
The American Heart Association concluded its first Healthier Together Conference in Dallas with a plenary on AI‑driven tools reshaping community health. Data science chief Jennifer Hall and Houston Methodist’s innovation officer Roberta Levy Schwartz outlined emerging AI applications and cautioned about...
Blood Pressure Drug Recalled After Failed Test
The FDA announced a Class II recall of 675 bottles of 20‑mg Enalapril Maleate tablets after a failed organic impurities test. The affected product, manufactured by Unique Pharmaceutical Laboratories (J.B. Chemicals & Pharmaceuticals) in India, was distributed across the U.S. by...
Encoded's Gene Therapy Reduced Seizures in Dravet Syndrome
Encoded Therapeutics reported that its experimental gene therapy cut seizure frequency by 76 % in three children with Dravet syndrome, a severe childhood epilepsy. The effect was seen in patients receiving the second‑highest dose among four dose levels in a small...
Innovaccer 2026 Payer AI Report: Nearly 80% of Insurers to Buy or Co-Develop AI Capabilities
Innovaccer’s 2026 Payer AI Report finds nearly 80% of health‑plan executives now prefer buying or co‑developing AI solutions, a stark reversal from 2024’s internal‑build focus. About three‑quarters of payers plan to allocate more than $10 million to AI‑driven payment and outcome...
Time for ‘Novel Ideals’: Rural Health Leaders Share Strategies Amid Budget Constraints
Sanford Health, the nation’s largest rural health system, is leveraging a $350 million virtual‑care initiative and a 60,000‑sq‑ft Virtual Care Center to sustain profitability while serving over 2 million patients across 300,000 square miles. The system’s hybrid model, which routes two‑thirds of virtual...
Carrot Expands AI Metabolic Health Program to Menopause
Carrot, the fertility‑focused health platform, is extending its AI‑driven Sprints metabolic program to address menopause. The expansion adds personalized nutrition, activity, sleep, and stress guidance, plus 24/7 coaching, specialist therapists, and access to hormone‑replacement therapy and GLP‑1 drugs when appropriate....
Cardiologists Are First in World to Use New Leaflet-Splitting Technique During TAVR
Interventional cardiologists performed the first‑in‑human transcatheter aortic root tricuspidization (ART) during transcatheter aortic valve replacement (TAVR) to treat bicuspid aortic stenosis. Seven symptomatic patients, average age 64.6, underwent ART‑assisted TAVR via transfemoral access with no 30‑day deaths or strokes. The...
Healthcare Philanthropy as Strategic Revenue: Why More Hospitals Are Rethinking Financial Growth
Hospitals face razor‑thin margins—just 1.3% in 2025—while labor costs rise 5.6% and Medicare reimburses only 83 cents per dollar of care. These pressures have pushed health systems to treat philanthropy as a strategic revenue source rather than a peripheral fundraiser....
Hospitals Are Treating Burnout as a Wellness Problem. It Is an Operating Model Problem
Hospitals treat physician burnout as a wellness issue, but the root cause is an operating model that piles administrative load, financial risk, and decision‑making away from clinicians. Studies show wellness interventions have little impact, while physicians now spend 15‑25 hours...
Glooko Announces FDA 510(k) Clearance for EndoTool IV Cloud
Glooko announced that the U.S. Food and Drug Administration granted 510(k) clearance for EndoTool IV Cloud, the first cloud‑based, patient‑specific insulin dosing platform for hospitals. The solution mirrors the proven algorithm of the on‑premise EndoTool IV but adds scalable, centralized deployment and reduced...
Ontario to Let Pharmacists Administer More Vaccines, Prescribe for More Ailments
Ontario announced a July 2026 expansion of pharmacists' scope, allowing them to administer six publicly funded vaccines—including tetanus, RSV and shingles—and to assess and prescribe for nine common minor ailments such as dandruff and mild headache. Pharmacy technicians will also...
Judge Blocks Trump Administration’s Demand for Rhode Island Hospital's Records of Transgender Kids
U.S. District Judge Mary McElroy ruled Wednesday that the Justice Department’s subpoena demanding Rhode Island Hospital’s records on transgender minors is invalid. The demand covered birth dates, Social Security numbers, addresses, treatment notes and side‑effect reports for five years of...
Roche Rolls Out Tecentriq SC Immunotherapy for Lung Cancer with the Promise of Less Treatment Time
Roche has launched its sub‑cutaneous form of Tecentriq (atezolizumab) in India, offering an immunotherapy for lung cancer that can be administered in about seven minutes versus several hours for traditional IV infusions. The SC version is priced at roughly ₹3.7 lakh...
Drug Ads Are Deceptive and Deadly
The Center for Economic and Policy Research reports that U.S. pharmaceutical firms are spending more than $10 billion a year on direct‑to‑consumer drug advertising, often using misleading claims to boost sales. These deceptive ads have been shown to increase prescription rates...
AstraZeneca Follows Merck with Phase 3 Win in Bladder Cancer
AstraZeneca announced that its checkpoint inhibitor Imfinzi, co‑developed with Pfizer, combined with Astellas’ antibody‑drug conjugate Padcev, significantly extended overall survival in a Phase 3 trial for advanced bladder cancer. The regimen outperformed the current standard of care, marking the company’s second...
'We're Right on Track,' Says Streeting as Key Target for Hospital Waiting Times Hit
The UK government met its interim NHS waiting‑time target, with 65.3% of patients treated within 18 weeks, just above the 65% goal for March 2026. The figure rose from under 59% when Labour took power and coincided with the overall waiting...
MacroGenics Sells Manufacturing Arm; West Pharma Discloses Cybersecurity Attack
MacroGenics announced the sale of its GMP‑manufacturing operations to Bora Pharmaceuticals, shifting its focus back to early‑stage antibody development. The transaction, terms undisclosed, transfers a fully qualified production suite and associated staff. In parallel, West Pharma disclosed a recent cybersecurity...
Our Aging Population Is Forcing a Rethink of How We Design & Package Medicines
Biopharma must redesign medicines for an aging population, as adults 65+ are rapidly growing and 89% of U.S. seniors use at least one prescription. Legacy child‑resistant packaging creates usability challenges, prompting the rise of child‑resistant, senior‑friendly (CRSF) solutions. Early integration...
How Remote Patient Monitoring Can Alleviate Staffing Strain and Improve Healthcare Delivery
Hospitals facing staffing shortages turn to remote patient monitoring (RPM) to extend care capacity. RPM integrates with major EHRs, delivering real‑time vitals and automating admin tasks so clinicians can focus on high‑need patients. Evidence from UPMC shows Medicare participants were...
Response to Infectious Diseases Caused by Hantaviruses in Japan
A BMJ rapid‑response letter from Japanese infectious‑disease specialists highlights a hantavirus outbreak linked to the cruise ship MV Hondius, with four Japanese passengers confirmed infected as of May 14, 2026. The World Health Organization classifies the public‑health risk as low, yet the...
How Penn Medicine Plans to Use AI to Train Their Doctors
Penn Medicine secured a $1.1 million American Medical Association education grant to develop AI‑driven tools that give medical trainees real‑time feedback on clinical reasoning. The project will deploy ambient artificial intelligence to record and analyze both peer‑to‑peer and patient‑facing conversations, using...
AstraZeneca Reports the P-III (VOLGA) Trial Data on Imfinzi + Enfortumab Vedotin (EV) for Muscle-Invasive Bladder Cancer
AstraZeneca presented Phase III VOLGA data showing that the combination of Imfinzi (durvalumab) and Enfortumab Vedotin improves event‑free survival and overall survival in muscle‑invasive bladder cancer patients who cannot receive cisplatin. The trial enrolled 695 patients undergoing radical cystectomy and compared two...
The World Must Not Turn Its Back on Vaccination
Global childhood immunization has stalled as financing fell up to 40 % since 2023, leaving half of the 14 million never‑vaccinated children in conflict‑affected zones. The World Health Assembly now faces a choice between renewed commitment to the most cost‑effective public‑health tool...
Employer Health Plan Facility Fees Targeted in Bipartisan House Bill
The bipartisan Transparency in Billing Act, reintroduced by Rep. Virginia Foxx and Rep. Robert Scott, seeks to stop hospitals from applying hospital‑level facility fees to services rendered in outpatient offices. The legislation would require health‑plan claims to include separate identifier...
Clinical Practice Telepsychiatry Expansion Showed Limited Gains in Reaching Rural, Underserved Patients
A recent JAMA Network Open analysis of telepsychiatry programs from 2024‑2025 shows a modest 12% rise in virtual mental‑health visits, but the expansion fell short of reaching rural and underserved populations. Rural patients comprised just 8% of all telepsychiatry sessions,...
BeOne Wins Mantle Cell Lymphoma Approval, Opening New Therapy Class
The FDA granted accelerated approval to BeOne Medicines’ BCL2 inhibitor sonrotoclax, marketed as Beqalzi, for patients with relapsed or refractory mantle‑cell lymphoma who have failed at least two prior therapies, including a BTK inhibitor. The drug is the first BCL2...
Alembic Pharma Gets USFDA Tentative Approval for Generic Prostate Cancer Drug
Alembic Pharmaceuticals received tentative USFDA approval for its 300 mg generic Darolutamide tablets, deemed therapeutically equivalent to Bayer’s Nubeqa. The approval applies to an Abbreviated New Drug Application, clearing a major regulatory hurdle for the Indian firm. Darolutamide targets prostate cancer...
FDA Hands BeOne, Taiho Approvals for Blood Cancers
BeOne Medicines’ BCL‑2 inhibitor Beqalzi (sonrotoclax) earned FDA accelerated approval as a third‑line treatment for mantle‑cell lymphoma, marking the first U.S. approval of a BCL‑2 drug for this indication. The approval is based on a phase 1/2 trial showing a 52%...
Regulatory Round-Up: A Month of Key FDA Approvals for Cancer Drugs
The FDA approved four oncology drugs in May 2026, marking a focused regulatory push in cancer therapeutics. Taiho Oncology received clearance for the oral Inqovi‑venetoclax regimen for elderly acute myeloid leukemia patients, while BeOne Medicines earned accelerated approval for Beqalzi...
The Beauty of Iteration
Anthony Guerra argues that iteration and low‑risk experimentation are essential for health‑system IT leaders, using his team’s evolution of raw interview recordings into SEO‑optimized YouTube Shorts as a case study. He stresses that near‑miss failures provide the richest learning, especially...
3 Physical Markers Beyond Blood Pressure That Can Predict Stroke Risk
A new UK Biobank analysis of 483,000 participants over 14 years identifies three simple physical markers—walking pace, grip strength, and muscle mass—that independently predict stroke risk. Slow walkers face a 64% higher risk, each 5 kg loss in grip strength adds...
Thinking About Stopping an Antidepressant? Here’s What to Consider.
Health Secretary Robert F. Kennedy Jr. announced initiatives encouraging people to consider stopping antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), while emphasizing that no one is being told to quit abruptly. The American Society of Clinical Psychopharmacology recently urged clinicians...
Behind The Raise: Peripear
Peripear, founded by former midwife Nina van Schaick, has built a hands‑free wearable that delivers therapeutic warmth to the perineum during crowning, reducing severe tears by up to 50 %. The device targets hospital labour units, with MOUs in Singapore covering...
Trump Demands Medicaid Data for Deportation. Some States Go a Step Further.
Republican‑led states are expanding federal immigration enforcement by requiring their public health agencies to report Medicaid recipients whose legal status is doubtful. North Carolina joined Indiana, Louisiana, Montana and Wyoming in passing laws that flag Medicaid users to the Department...
License To Deliver: Some Midwives Break the Law To Assist With Home Births
In Georgia, certified professional midwives (CPMs) who attend home births operate illegally, facing cease‑and‑desist letters or criminal charges. Demand for home births has surged, up 72% in the state and 42% nationwide since 2020, prompting advocates to push for licensing...
Osel and Partners Launch Phase IIb FLIP-2 Trial of Lactin-V
Osel, Imperial College London and the March of Dimes have launched the Phase IIb FLIP‑2 trial to evaluate Lactin‑V, a live‑biotherapeutic containing Lactobacillus crispatus, for preventing preterm birth in high‑risk pregnancies. The study will enroll 360 women across four UK maternity...
Pfizer Receives EC Approval for Hympavzi to Treat Haemophilia
Pfizer secured European Commission marketing authorisation for Hympavzi (marstacimab) to treat hemophilia A or B with inhibitors in patients aged 12 years and older weighing at least 35 kg. The once‑weekly subcutaneous therapy showed a 93% reduction in mean annualised bleeding rate versus on‑demand...
Reimbursement Potential of Collaborative Care Model (CoCM) Billing Codes for Opioid Use Disorder Co-Occurring with Mental Disorders
A RAND‑sponsored pragmatic trial evaluated how Medicare’s Collaborative Care Model (CoCM) billing codes translate into revenue for treating opioid use disorder with co‑occurring depression or PTSD. Across 381 patients and 90,996 care‑manager minutes, only 56% of activity met billing criteria,...